Image

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Investigational Medication Study for Advanced Refractory Solid Tumors

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced refractory solid tumors. The purpose of this study is to evaluate the investigational medication in patients with these types of tumors.

The study will focus on assessing the safety and effectiveness of the investigational medication. It will look at how well patients tolerate the treatment and any side effects they may experience.

  • Who can participate: Adults 18 years or older with advanced solid tumors that have no standard treatment options may join. Participants must agree to use contraception and have adequate organ function.
  • Study details: Participants will receive an investigational medication. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
  • Study timelines: The study will last 48 months.
Print
Study details
    Prostate Cancer Castration-resistant Prostate Cancer
    Breast Cancer
    Colo-rectal Cancer
    Lung Cancer (Non-Small Cell)
    Pancreas Cancer
    Duct Cell Adenocarcinoma

NCT07145255

MBrace Therapeutics

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.